Concepedia

Julia Tietz

JT

Statistics

Publications

6

Citations

214

H-Index

6

Active since

2010

Affiliations

Agile Therapeutics (United States)(Current)

Julia Tietz is an author at Agile Therapeutics (United States) specializing in medicine, pharmacology, and antibody engineering.

ORCID

Publications per year

2010–2024

6

Publications

6

Generic Approach for the Generation of Stable Humanized Single-chain Fv Fragments from Rabbit Monoclonal Antibodies

Leo Borras, Tea Gunde, Julia Tietz et al. · Journal of Biological Chemistry · 2010 · 64 citations · Full text

, , +17

Affinity and Potency of RTH258 (ESBA1008), a Novel Inhibitor of Vascular Endothelial Growth Factor A for the Treatment of Retinal Disorders

Julia Tietz, Gunther Spohn, G. M. Schmid et al. · Investigative Ophthalmology & Visual Science · 2015 · 46 citations

, , +15

Preclinical Pharmacology and Safety of ESBA1008, a Single-chain Antibody Fragment, Investigated as Potential Treatment for Age Related Macular Degeneration

Jacques Gaudreault, Tea Gunde, Heather S. Floyd et al. · Investigative Ophthalmology & Visual Science · 2012 · 45 citations

, , +12

Engineering of a trispecific tumor-targeted immunotherapy incorporating 4-1BB co-stimulation and PD-L1 blockade

Stefan Warmuth, Tea Gunde, Daniel Snell et al. · OncoImmunology · 2021 · 35 citations · Full text

, , +17

A Bispecific, Tetravalent Antibody Targeting Inflammatory and Pruritogenic Pathways in Atopic Dermatitis

Julia Tietz, Tea Gunde, Stefan Warmuth et al. · JID Innovations · 2024 · 13 citations · Full text

, , +17

1–5 of 6